SCHEMBL19331213

SCHEMBL19331213

Cc1c(C(=O)NC2(c3cccc(C(=O)O)c3)CCCNC2)[nH]c2ccc(Cl)c(Cl)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A9 P48067 2/20 0.37
▸ ROCK2 O75116 2/20 0.34
▸ ROCK1 Q13464 2/20 0.34
▸ GRIN1 Q05586 1/20 0.34
▸ F9 P00740 2/20 0.33
▸ WDR5 P61964 1/20 0.32
▸ CREBBP Q92793 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ DYRK1B Q9Y463 1/20 0.32
▸ PHGDH O43175 1/20 0.32
▸ MCL1 Q07820 2/20 0.32
▸ KCNA3 P22001 1/20 0.32
▸ TOP2A P11388 1/20 0.31
▸ EGFR P00533 1/20 0.31
▸ TACR2 P21452 1/20 0.31
▸ AKT1 P31749 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19331205 0.83 SLC6A9 (0.37) SLC6A9GRIN1F9WDR5MAPT
SCHEMBL19331168 0.80 POLB (0.38) F9WDR5CREBBPPHGDHTACR2
Hydrochloric Acid SCHEMBL19331242 0.80 KDM4E (0.37) DYRK1ADYRK1BAKT1LMNAMAPT
SCHEMBL19330891 0.80 SLC6A9 (0.34) SLC6A9F9WDR5MAPTSMN1; SMN2
SCHEMBL20768402 0.76 PHGDH (0.59) SLC6A9F9PHGDH
SCHEMBL19331120 0.74 PHGDH (0.47) PHGDHEGFR
SCHEMBL19331329 0.73 PHGDH (0.42) GRIN1PHGDHMCL1EGFR
SCHEMBL19331006 0.71 ALDH1A1 (0.37) LMNAMAPTSMN1; SMN2
SCHEMBL19330953 0.70 PHGDH (0.41) PHGDHEGFRAKT1
SCHEMBL19331111 0.70 PHGDH (0.37) PHGDHEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426243-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF Raze Therapeutics Inc. (US) 2019-01-16 — — EP disclosed
WO-2017156165-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-09-14 — — WO disclosed
Send feedback